PD-1 blockade potentiates neoadjuvant chemotherapy in NSCLC via increasing CD127+ and KLRG1+ CD8 T cells.
Hui Z, Ren Y, Zhang D, Chen Y, Yu W, Cao J, Liu L, Wang T, Xiao S, Zheng L, Pu Y, Wei F, You J, Ren X.
Hui Z, et al. Among authors: chen y.
NPJ Precis Oncol. 2023 May 25;7(1):48. doi: 10.1038/s41698-023-00384-x.
NPJ Precis Oncol. 2023.
PMID: 37231145
Free PMC article.